Home/ Supplements/ Niacin/ Rezistaf

Rezistaf

product on market Tablet or Pill LifeLink Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Nicotinamide is used to support cellular energy metabolism and skin health. Current research provides moderate evidence for its role in maintaining DNA repair mechanisms. Due to the limited evidence coverage for this specific formulation, clinical data on the overall product profile is sparse.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Rezistaf
Open Full PDF View on NIH DSLD →
Details

Label Data

5 Tablet(s)
Serving Size
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

5 Gram(s)
Within RDA (0.4× RDA) 196 studies (A:5, B:63)

Other Ingredients

Dicalcium Phosphate Magnesium Stearate Alginic Acid
Claims

Label Claims — Verification

Unverified No Claim
Info

Product Information

Directions for Use

Suggested Use: 5 tablets twice per day.

Formulation Notes

NAM (nicotinamide) is a form of vitamin B3.

High-purity NAM

Additional Information

500

NAM (nicotinamide) is a form of vitamin B3. (It is biologically unrelated to the alkaloid nicotine, and is not habit-forming.) NAM has been found to stimulate the part of the immune system responsible for the killing of Staphylococcus aureus- the bacterium responsible for antibiotic resistant staph infections, such as MRSA and "flesh eating disease".

Metadata

Product Details

UPC / SKU6 39793 90107 4
DSLD Entry Date2017-01-25
Product TypeVitamin
FormTablet or Pill
DSLD ID70239
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.